Scott Bergman

588 total citations
42 papers, 276 citations indexed

About

Scott Bergman is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Scott Bergman has authored 42 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Infectious Diseases and 14 papers in Pharmacology. Recurrent topics in Scott Bergman's work include Antibiotic Use and Resistance (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antifungal resistance and susceptibility (8 papers). Scott Bergman is often cited by papers focused on Antibiotic Use and Resistance (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antifungal resistance and susceptibility (8 papers). Scott Bergman collaborates with scholars based in United States. Scott Bergman's co-authors include Kelly M Percival, Janak Koirala, McKenzie Ferguson, Trevor Van Schooneveld, Michael Short, Donald R. Graham, Marc H. Scheetz, Andrew Watkins, Arne Forsgren and Milena M. McLaughlin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bacteriology and Infection Control and Hospital Epidemiology.

In The Last Decade

Scott Bergman

41 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Bergman United States 9 123 81 80 60 35 42 276
Endre Ludwig Hungary 11 243 2.0× 40 0.5× 76 0.9× 58 1.0× 52 1.5× 34 403
Edward L. Goodman United States 7 107 0.9× 113 1.4× 136 1.7× 74 1.2× 25 0.7× 10 358
Christine E. MacBrayne United States 13 101 0.8× 70 0.9× 79 1.0× 126 2.1× 14 0.4× 35 343
Farnaz Foolad United States 11 172 1.4× 57 0.7× 59 0.7× 107 1.8× 17 0.5× 18 357
Jonas Bredtoft Boel Denmark 10 190 1.5× 66 0.8× 45 0.6× 75 1.3× 17 0.5× 39 425
Anders Lannergård Sweden 10 221 1.8× 46 0.6× 31 0.4× 60 1.0× 45 1.3× 18 363
Kazuhiro Uda Japan 11 164 1.3× 100 1.2× 29 0.4× 56 0.9× 34 1.0× 61 350
Caroline Chen Australia 9 62 0.5× 83 1.0× 125 1.6× 66 1.1× 15 0.4× 16 304
Yasuaki Tagashira Japan 11 161 1.3× 106 1.3× 32 0.4× 75 1.3× 13 0.4× 36 351
Manal Algethamy Saudi Arabia 10 73 0.6× 118 1.5× 35 0.4× 109 1.8× 23 0.7× 20 293

Countries citing papers authored by Scott Bergman

Since Specialization
Citations

This map shows the geographic impact of Scott Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bergman more than expected).

Fields of papers citing papers by Scott Bergman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bergman. The network helps show where Scott Bergman may publish in the future.

Co-authorship network of co-authors of Scott Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Bergman. A scholar is included among the top collaborators of Scott Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Bergman. Scott Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
May, Sara, et al.. (2024). Perioperative cefazolin prescribing rates following suppression of alerts for non-IgE-mediated penicillin allergies. Infection Control and Hospital Epidemiology. 45(9). 1110–1114. 1 indexed citations
2.
Lyden, Elizabeth, et al.. (2023). Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone. Open Forum Infectious Diseases. 10(12). ofad606–ofad606. 3 indexed citations
3.
Marcelin, Jasmine R, et al.. (2023). Impact of specialty on the self-reported practice of using oral antibiotic therapy for definitive treatment of bloodstream infections. SHILAP Revista de lepidopterología. 3(1). e48–e48. 1 indexed citations
4.
Schooneveld, Trevor Van, et al.. (2023). Implementation of a Rapid Multiplex Polymerase Chain Reaction Pneumonia Panel and Subsequent Antibiotic De-escalation. Open Forum Infectious Diseases. 10(8). ofad382–ofad382. 7 indexed citations
5.
6.
7.
Chung, Philip, Muhammad Salman Ashraf, Scott Bergman, et al.. (2021). Improving antibiotic prescribing for acute bronchitis in the ambulatory setting using a multifaceted approach. Infection Control and Hospital Epidemiology. 43(9). 1235–1237. 4 indexed citations
8.
Puzniak, Laura, et al.. (2021). 1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy. Open Forum Infectious Diseases. 8(Supplement_1). S730–S730. 1 indexed citations
9.
Schooneveld, Trevor Van, et al.. (2019). Use of a best practice alert linking Clostridioides difficile infection test results to a severity-based treatment order set. Infection Control and Hospital Epidemiology. 40(4). 467–469.
10.
Miller, Brian, et al.. (2016). Micafungin and a case of polymorphic ventricular tachycardia. Journal of Clinical Pharmacy and Therapeutics. 41(3). 362–364. 4 indexed citations
11.
Prakash, Vidhya, et al.. (2016). Comparison of Posaconazole and Itraconazole for treatment of Histoplasmosis. Open Forum Infectious Diseases. 3(suppl_1). 7 indexed citations
12.
Bergman, Scott, et al.. (2016). Outcomes of an extended-infusion piperacillin-tazobactam protocol implementation in a community teaching hospital adult intensive care unit. American Journal of Health-System Pharmacy. 73(11_Supplement_3). S100–S105. 11 indexed citations
13.
Huang, Vanthida, Michael E. Klepser, Paul O. Gubbins, et al.. (2015). Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharmacy Education. 15(1). 1–6. 4 indexed citations
14.
Percival, Kelly M, et al.. (2015). Impact of an antimicrobial stewardship intervention on urinary tract infection treatment in the ED. The American Journal of Emergency Medicine. 33(9). 1129–1133. 56 indexed citations
15.
Modi, Jignesh, et al.. (2012). Possible antagonism with use of ceftaroline and rifampin to treat methicillin-resistant Staphylococcus aureus infection. International Journal of Infectious Diseases. 16. e421–e421. 1 indexed citations
16.
Bergman, Scott, et al.. (2012). Update on Human Papillomavirus Vaccines: Life Saver or Controversy Magnet?. Clinical Microbiology Newsletter. 34(11). 85–91. 2 indexed citations
17.
Bergman, Scott, et al.. (2011). Interferons as Therapeutic Agents for Infectious Diseases. Infectious Disease Clinics of North America. 25(4). 819–834. 26 indexed citations
18.
Bergman, Scott, et al.. (2008). Famciclovir substitution for patients with acyclovir-associated renal toxicity. Journal of Infection. 57(3). 266–268. 12 indexed citations
19.
Bergman, Scott, et al.. (2007). Pharmacokinetic and Pharmacodynamic Aspects of Antibiotic Use in High-Risk Populations. Infectious Disease Clinics of North America. 21(3). 821–846. 24 indexed citations
20.
Bergman, Scott, et al.. (1954). Studies on an inhibitor of streptomycin and neomycin of bacterial origin.. PubMed. 4(5). 493–501. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Endre Ludwig Breakdown of academic impact, for papers by Edward L. Goodman Breakdown of academic impact, for papers by Christine E. MacBrayne Breakdown of academic impact, for papers by Farnaz Foolad Breakdown of academic impact, for papers by Jonas Bredtoft Boel Breakdown of academic impact, for papers by Anders Lannergård Breakdown of academic impact, for papers by Kazuhiro Uda Breakdown of academic impact, for papers by Caroline Chen Breakdown of academic impact, for papers by Yasuaki Tagashira Breakdown of academic impact, for papers by Manal Algethamy
Rankless by CCL
2026